Abstract
Thirty patients with hepatocellular carcinoma (HCC) were treated with transcatheter arterial embolization therapy (TAE) and its therapeutic effects were evaluated mainly by follow-up angiography.
The tumorous shadows disappeared or the size of the tumors reduced in 24 of 30 cases (80%) on follow-up angiograms. In 5 cases the disappearance of the tumor stain was obtained and continued for more than 1 year. In 4 of these 5 cases, the tumors disappeared with the first TAE. In 3 cases, the tumor was solitary with the size of less than 3cm and located at peripheral parts of posterior, inferior subsegments of the liver.
These findings suggest that the effect of TAE depends on the number, the size and the location of the tumor in the liver. Patients with HCC having these conditions are considered to be good candidates for TAE.
